These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27612499)

  • 1. Diabetes Is Associated With Decreased Limb Survival in Patients With Critical Limb Ischemia: Pooled Data From Two Randomized Controlled Trials.
    Spreen MI; Gremmels H; Teraa M; Sprengers RW; Verhaar MC; Statius van Eps RG; de Vries JP; Mali WP; van Overhagen H;
    Diabetes Care; 2016 Nov; 39(11):2058-2064. PubMed ID: 27612499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
    Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
    Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
    Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S
    J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia.
    Spreen MI; Martens JM; Knippenberg B; van Dijk LC; de Vries JPM; Vos JA; de Borst GJ; Vonken EPA; Bijlstra OD; Wever JJ; Statius van Eps RG; Mali WPTM; van Overhagen H
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) trial.
    Teraa M; Sprengers RW; Schutgens RE; Slaper-Cortenbach IC; van der Graaf Y; Algra A; van der Tweel I; Doevendans PA; Mali WP; Moll FL; Verhaar MC
    Circulation; 2015 Mar; 131(10):851-60. PubMed ID: 25567765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
    Zeller T; Micari A; Scheinert D; Baumgartner I; Bosiers M; Vermassen FEG; Banyai M; Shishehbor MH; Wang H; Brodmann M;
    JACC Cardiovasc Interv; 2020 Feb; 13(4):431-443. PubMed ID: 32081236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss.
    Vallabhaneni R; Kalbaugh CA; Kouri A; Farber MA; Marston WA
    J Vasc Surg; 2016 Jan; 63(1):105-12. PubMed ID: 26412436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia.
    Westin GG; Armstrong EJ; Bang H; Yeo KK; Anderson D; Dawson DL; Pevec WC; Amsterdam EA; Laird JR
    J Am Coll Cardiol; 2014 Feb; 63(7):682-690. PubMed ID: 24315911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemia.
    Singh GD; Armstrong EJ; Waldo SW; Alvandi B; Brinza E; Hildebrand J; Amsterdam EA; Humphries MD; Laird JR
    Vasc Med; 2017 Jun; 22(3):210-217. PubMed ID: 28466753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions.
    Iida O; Soga Y; Yamauchi Y; Hirano K; Kawasaki D; Yamaoka T; Takahara M; Uematsu M
    J Vasc Surg; 2013 Apr; 57(4):974-981.e1. PubMed ID: 23375608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Postoperative Percutaneous Coronary Intervention, Pharmacologic Treatment, and Predisposing Factors on Clinical Outcomes in Patients With and Without Type 2 Diabetes Along With Critical Limb Ischemia.
    Lee CY; Wu TC; Lin SJ
    Clin Ther; 2021 Jan; 43(1):195-210.e2. PubMed ID: 33358255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High and immeasurable ankle-brachial index as predictor of poor amputation-free survival in critical limb ischemia.
    Spreen MI; Gremmels H; Teraa M; Sprengers RW; Martens JM; Verhaar MC; Wever JJ; de Borst GJ; Vos JA; Mali WPTM; van Overhagen H;
    J Vasc Surg; 2018 Jun; 67(6):1864-1871.e3. PubMed ID: 29290494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification in patients with no-option chronic limb-threatening ischemia.
    van Haelst STW; Teraa M; Moll FL; de Borst GJ; Verhaar MC; Conte MS
    J Vasc Surg; 2018 Oct; 68(4):1104-1113.e1. PubMed ID: 29802042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions.
    Iida O; Soga Y; Hirano K; Kawasaki D; Suzuki K; Miyashita Y; Terashi H; Uematsu M
    J Vasc Surg; 2012 Feb; 55(2):363-370.e5. PubMed ID: 22051875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia.
    Vierthaler L; Callas PW; Goodney PP; Schanzer A; Patel VI; Cronenwett J; Bertges DJ;
    J Vasc Surg; 2015 Sep; 62(3):655-64.e8. PubMed ID: 26215708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia.
    Chung J; Modrall JG; Ahn C; Lavery LA; Valentine RJ
    J Vasc Surg; 2015 Jan; 61(1):162-9. PubMed ID: 25073577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Drug-Eluting Stents for Infrapopliteal Lesions in Patients with Critical Limb Ischemia: The PADI Trial.
    Wakkie T; Konijn LCD; van Herpen NPC; Maessen MFH; Spreen MI; Wever JJ; Statius van Eps RG; Veger HT; van Dijk LC; Mali WPTM; van Overhagen H
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):376-381. PubMed ID: 31807849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
    Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
    J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.